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Summary 
The Fc-IgG receptor (FcR)-mediated function of mononuclear phagocyte 
system (MPS) was investigated in 22 patients with systemic lupus erythematosus 
(SLE) and 10 control volunteers. The FcR binding capacity of peripheral mono-
cytes was measured by 125-1-labelled bovine serum albumine (BSA) anti-bovine 
serum albumine (aBSA) complex. The mean value of FcR-s was increased and 
the association constant (Ka) decreased in SLE group compared to the controls 
but the differences did not reach statistical significance. The clearance half-time 
of 51-Cr labelled and anti-D IgG sensitized autologous red blood cells was signi-
ficantly increased in the SLE group (P<0.05). 
Mowever, the analysis of the individual data of patients showed a correlation 
between in vitro and in vivo FcR mediated function (r= —0.54, P<0.01). The 
prolonged clearance half-time was accompanied by lower FcR number of peri-
pheral monocytes in the same patient. These data suggest that the normal or even 
elevated numbers of FcR-s are not able to compensate the diminished phagocyte 
function of MPS in SLE. 
Introduction 
Impaired clearance of anti-D IgG sensitized, 51-Cr labelled erythrocytes was 
found in systemic lupus erythematosus (SLE) by several investigators. These 
erythrocytes are trapped by cells of mononuclear phagocyte system (MPS) in 
the spleen via their Fc-IgG receptors (FcR) [2, 4, 14]. 
In contrast to the functional defect of MPS observed in vivo, we and others 
found normal or elevated FcR numbers on the surface of monocytes from 
patients with SLE. Increased FcR function was demonstrated by the binding 
of IgG sensitized bovine erythrocytes, radiolabeled IgG monomers and oligo-
mers [3, 6, 12]. 
The aim of the recent study was to analyse further the connection between 
Fc receptor function of peripheral monocytes and splenic macrophages with 
sensitive and quantitative methods in a fair number of SLE patients. We 
measured the in vivo clearance of anti-D IgG sensitized erythrocytes in parallel 
with FcR number and binding association constant (Ka) of monocytes in 
22 SLE patients and 10 control volunteers. The FcR number was measured by 
using bovine serum albumine (BSA) 125-I-labelled anti-BSA rabbit IgG 
complex (BSA-aBSA). Our results suggest a correlation between FcR binding 
capacity of monocytes and MPS clearance function in SLE. 
Patients and methods 
Selection of patients 
Twenty-two SLE patients (19 women and 3 men, their age ranging 19-—66 years) 
were studied. Each patient had four or more of the American Rheumatism Association 
(ARA) preliminary criteria [1]. Eight of the patients were considered to have active 
disease and 14 of them were in inactive state. The clinical activity was defined on the 
basis of Lupus Activity Criteria Count [13]. 
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The correlation with laboratory parameters was not an aim of attention in the recent 
study because we studied earlier the clearance rate of sensitized erythrocytes as a func-
tion of antibodies to EN A and immune complexes [7]. 
Patients received the following daily doses of prednisone: none, two patients; 1 to 
10 mg, five patients; 11 to 20 mg, ten patients; 21 to 30 rag, four patients. One patient 
with active disease was receiving 50 mg azathioprine and 20 mg prednisone. 
In addition, 10 volunteers (5 women and 5 men, 35—62 years of age) participated in 
the study as controls. They had no inflammatory or autoimmune diseases and were not 
receiving anti-inflammatory or cytotoxic therapy. Informed consent was obtained from 
all participants. 
Measurement of whole-blood clearance of IgG sensitized autologous red blood cells 
FcR-mediated MPS studies were performed with a slight modification of a previously 
described method by Lockwood et al. [8]. Six ml of citrated blood was collected from 
each person. After centrifugation 1 ml of packed red blood cells were incubated 50 ^Ci 
of 51-Cr (Na2Cr04 from Poland) at 37 °C for 10 min, and then washed once with physio-
logical salt solution (PSS). After washing the cells were incubated with 50 ug of anti-D 
IgG (OHVI, Budapest) for 15 min at 37 °C and washed twice with PSS. The volume was 
adjusted to 5 ml with PSS before reinjection. The cells were injected intravenously over 
60 sec. Starting three minutes after the midpoint time of the injection 5 ml blood sam-
ples were removed at five minutes intervals for 20 min. Radioactivity per unit volume 
of blood was measured in a gamma counter (Gamma, Budapest). The clearance half-
time was calculated on the basis of exponential disappearance of labelled erythrocytes 
from the circulation. 
Preparation of monocytes 
Monocytes were isolated by using the Ficoll-Hypaque gradient centrifugation, fol-
lowed by adherence [9]. In brief, the monocyte rich fraction was incubated in tissue cul-
ture polystirene plates (Linbro 76-003-05) for 60 min at 37 °C in C02 atmosphere (2 X 106 
cells/well). After removing the non-adherent cells, the adherent ones were positive 
esterase-stained (85—90%), viable (95—98%) monocytes (3—6 Xl05/well). 
Binding of immune complexes by monocytes 
The adherent cells were incubated with various doses of BSA-aBSA complex (con-
taining 50 to 300 ng IgG) in 100 ul Parker medium balanced with HEPES (pH 7.4) con-
taining 0.5% ovalbumine for 4 hours at 4 °C. The immune complex (IC) was obtained 
from BSA and anti-BSA-rabbit IgG prepared at a molar ratio 1 : 1 , which represented 
antigen-antibody complex formed in moderate antibody excess. The anti-BSA was la-
belled with 125-1 to a specific activity of 0.5 mCi/mg by the jodogen method. In parallel 
wells cold IgG was put at least 100-fold molar excess over the labelled ligand. Other 
parallel wells were set up containing labelled BSA-aBSA but no cells. Assays were done 
in duplicate. After incubation supernatants were aspirated and the washed cell pellets 
were dissolved in 0.5 N NaOH for quantification of 125-1 and cell count [9]. Binding 
data, corrected for nonsaturable component, were analyzed by the method of Scat-
chard [10]. 
Statistical analysis 
The statistical significance (P) of the differences between the groups was calculated 
using Student's t test. The correlation coefficient (r) and its significance (P) were cal-
culated from straight line equation. 
Results 
Fc receptor-mediated immune clearance 
A significant difference was found between Fc receptor-mediated immune 
clearance of SLE patients and normal controls as shown in Table I. 
Values of clearance half-time measured in subsets of patients with inactive 
(24+10.2 min) and active disease (34.38 + 26.4 min) tended to increase with 
disease activity (Fig. 1.). Only one of 10 control volunteers had suppressed 
MPS function. 
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Table I. 
Clearance half-time of labelled and sensitized red blood cells, FcR number and binding 
association constant (Ka) of peripheral monocytes measured by BSA-aBSA in 22 
patients with SLE and 10 control volunteers 
Measured data Units 
Pts with SLE 
(22) 
mean + SD 
Controls 
(10) 
± S D 
Significance 
Clearance half-time 
Fc receptor number 
Ka of BSA-aBSA 
binding to monocytes 
min 
n/cell 
xlO5 
xlO7 
M- 1 
27.6+18 
2.98 + 2.1 
4.81 + 1.95 
17.22 + 6 
2.47 + 0.76 
5.73 + 2.3 
P <0.05 
NS 
NS 
T-i/2 min 
1 
3 5 1 
30 H 
20-I 
15 
10 
5H 
P
. - i , < 0 ' 0 5 
SD 
II 
Control 
(10) 
SLE 
(22) 
SLE 
inactive 
(14) 
SLE 
active 
(8) 
Figure 1. Clearance half-time (T1/2) of 51-Cr labelled, anti-D IgO sensitized red 
blood cells in 10 control volunteers and 22 SLE patients. The patients with SLE 
were divided in inactive (14) and active (8) groups 
Immune complex binding by Fc receptor of monocytes 
As it shown in Table I the monocytes from SLE patients tended to have 
increased FcR number but no significant difference was found between the 
SLE and control group. The mean association constant value for FcR binding 
of BSA-aBSA complex was decreased in the SLE group but did not differ 
significantly from the normals (Table I). Reverse correlation was found be-
tween the FcR number and the Ka either in the SLE group and the control 
group but they did not reach the level of statistical significance (Table II). 
Correlation between MPS clearance and binding of BSA-aBSA by monocytes 
Studying the SLE group we noted that a significant negative correlation was 
present between clearance half-time and FcR number of peripheral monocytes 
34 
Table II. 
Correlation between FcR number 
(FcE), binding association 
constant (Ka) of monocytes and 
clearance half-time (Tll2) of labelled 
and sensitized red blood cells in 22 
SLE patients and 10 control volunteers 
Correlation 
coefficients 
(r) 
rFcR 
i-FcR 
i ' K a -
T 1 / 2 min 
, 
70-
60-
50-
40-
30-
20-
10-
• 
—Ka 
- T i , 2 
-T 1 / 2 
• 
0 
• 
• • 
• 
• 
• 
SLE 
patients 
(22) 
-0 .400 
NS 
-0 .544 
P<0 .01 
0.426 
P < 0 . 0 5 
Y=41,86-4,715 
• 
• 
•• > s 
• 
• 
Controls 
(10) 
-0 .488 
NS 
- 0 . 5 9 
NS 
0.388 
NS 
X 
^ N , . • 
5 6 7 ft R 
n/cellx105 
Figure 2. Correlation between FcR number of peripheral monocytes and clearance 
half-time (T1/2) of sensitized red blood cells (r = —0.54, P<0.01) 
(Table 2, Fig. 2). Fiirther investigation of this phenomenon detected a signi-
ficant positive correlation between clearance half-time and association constant 
(Table II). In the control group similar suggestive correlations were found but 
these did not reach statistical significance (Table II). 
Discussion 
In the present experiment the FcR-mediated function of MPS was investiga-
ted in vitro and in vivo in SLE and control groups. The qualitative and quanti-
tative properties of FcR appeared characteristic of FcR ligand binding. In our 
study the FcR binding capacity of peripheral monocytes was measured by 
using BSA-aBSA complexes because the number of FcR sites for immune 
complexes (IC) were much higher than for IgG monomers [3]. The in vitro 
interaction between BSA-aBSA and monocytes might be a model of in vivo 
interactions of circulating IC and monocytes in SLE patients. 
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The mean value of FcR number was higher in our SLE group than in controls 
but the difference was not significant. At the same time a decreased mean 
value of the association constant (Ka) was revealed. Similar tendency was 
described by others used monomer and oligomer IgG [3]. Decreased FeR-ligand 
binding was published by using aggregated IgG as ligand [5]. This discrepancy 
may be related to the different behaviour of IgG monomer, oligomer and 
aggregated IgG. 
The in vivo clearance of sensitized and labelled erythrocytes was measured 
parallely in the same patients. Similarly to earlier findings [2, 4] a significantly 
prolonged clearance half-time ( T ^ ) was revealed in the SLE group. Further-
more our data suggest that this method can be useful to estimate the disease 
activity of patients with SLE. 
The SLE group with elevated or normal FcR numbers of peripheral mono-
cytes had prolonged T1/2. However, comparing these two data in each patient 
we could show that the longer T1/2 was associated with lower FcR number 
of peripheral monocytes in the same patient. As it was shown there was a reverse 
correlation between the FcR number and T1/2 in SLE. The tendency was 
similar in the control group. 
This analysis of individual data may help to resolve the paradox findings 
observed by us and others namely that decreased FcR-mediated MPS clearance 
exists in SLE despite normal or elevated FcR numbers of the monocytes [3, 12]. 
On the other hand it was published recently that the FcR-mediated in vitro 
internalisation of sensitized erythrocytes by SLE monocytes was decreased 
comparing to controls [11, 12]. This and our data suggest that the elevation 
of FcR numbers can not compensate the decreased phagocyte function of MPS 
in SLE. Furthermore, the alteration of phagocyte function may not be caused 
by circulating IC saturation of FcR-s. 
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